| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 42 |
| 1 | TESTOSTERONE | 42 |
| 2 | ANASTROZOLE | 25 |
| 3 | ANASTROZOLE TABLETS | 25 |
| 4 | PREDNISONE | 24 |
| 5 | CABERGOLINE | 23 |
| 6 | MIRTAZAPINE | 21 |
| 7 | DUPILUMAB | 20 |
| 8 | FLUTICASONE FUROATE | 20 |
| 9 | OMALIZUMAB | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TESTOSTERONE ENANTHATE | 9 | 0.0055 |
| 1 | CABERGOLINE | 23 | 0.0047 |
| 2 | FLECAINIDE ACETATE | 14 | 0.0026 |
| 3 | TRIMIPRAMINE MALEATE | 1 | 0.0025 |
| 4 | PIROXICAM | 16 | 0.0025 |
| 5 | CICLOPIROX OLAMINE | 1 | 0.0021 |
| 6 | TESTOSTERONE UNDECANOATE | 4 | 0.0020 |
| 7 | ALLOPURINOL SODIUM | 1 | 0.0018 |
| 8 | TESTOSTERONE | 42 | 0.0018 |
| 9 | MECASERMIN | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 59 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 43 |
| 2 | Androgen [EPC] | 43 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 4 | Aromatase Inhibitor [EPC] | 28 |
| 5 | Opioid Agonist [EPC] | 26 |
| 6 | Atypical Antipsychotic [EPC] | 25 |
| 7 | Ergot Derivative [EPC] | 23 |
| 8 | Benzodiazepine [EPC] | 21 |
| 9 | Anti-IgE [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 23 | 0.0047 |
| 1 | Androgen [EPC] | 43 | 0.0016 |
| 2 | Anticholinergic [EPC] | 16 | 0.0010 |
| 3 | Recombinant Human Growth Hormone [EPC] | 12 | 0.0005 |
| 4 | Interleukin-17A Antagonist [EPC] | 16 | 0.0004 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 43 | 0.0004 |
| 6 | Cholinergic Muscarinic Antagonist [EPC] | 16 | 0.0004 |
| 7 | Cannabinoid [EPC] | 3 | 0.0004 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 16 | 0.0003 |